Work

DCE-MRI Evaluation of 10 patients with brain metastases treated with RRx-001, a Myc inhibitor and a CD47 and PD-L1 downregulator, in a phase I/II trial called BRAINSTORM.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.e14509

Authors: Michelle Miran Kim, Hemant Parmar, Madhava P Aryal, Scott Caroen, Theresa Devasia, Matthew J Schipper, Aki Morikawa, Daniel Eidelberg Spratt, James Hayman, Larry Junck, Theodore Steven Lawrence, Christopher D. Lao, Yue Cao

Institutions: The University of Texas MD Anderson Cancer Center, University of Michigan, EpicentRx, Inc. (United States), Michigan Medicine, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Brain Metastases and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3029000066

Cites:

Cited by:

Related to: 10